Self-administered therapy inhibits interleukin-6 receptors ...

The supplemental indication for satralizumab, already sold for a rare neuroinflammatory disease, is another example of the recent marked growth in approved treatments for thyroid eye disease.

The FDA approved Enspryng (satralizumab) on Oct. 16 for adults with thyroid eye disease (TED). 1 Roche describes the ...

Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, ...

Please provide your email address to receive an email when new articles are posted on . The most common manifestations are blepharokeratoconjunctivitis, anterior blepharitis, chalazia and phlyctenular ...

Genentech, part of the Roche Group (RHHBY), said the FDA approved Enspryng (satralizumab-mwge) to treat adults with thyroid ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The ocular surface hosts a low-abundance microbial community that may help regulate immune defenses, while changes in its ...

Please provide your email address to receive an email when new articles are posted on . Dry eye, conjunctivitis, keratitis and other eye diseases were less frequent with the use of biologics vs. other ...

Scientists have discovered a hidden cleanup system at the back of the eye that drains fluid and waste through a previously ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...